Lumida
/GILD
⌘K
Gilead Sciences Inc

Gilead Sciences Inc

GILD
$143.72USD↓-0.75%-1.09 today

MARKET CAP

178.2B

P/E (TTM)

—

FWD P/E

15.5x

DAY RANGE

$144 – $146

52W RANGE

$108
$157

AI Summary

Stalk
Sell NowMedium

GILD is in Stage 3 distribution with a bearish medium-term bias. Price is forming successive lower highs and lower lows below the declining 9/20 EMAs, signaling continued seller control. Short-term momentum confirms execution readiness, so selling into the dynamic resistance around the 9/20 EMA cluster (~144.90–146.45) is appropriate. Key support lies near 138.10, while the long-term uptrend remains intact but is currently overshadowed by the bearish structure.

  • ↑Q2 product sales rose 10% YoY to $7.6B, driven by HIV portfolio
  • ↑HIV sales up 12% to $5.7B, boosted by FDA approval of Bixlenvo
  • ↓Operating margin stood at –94% in Q2, driven by major acquisition expenses
Full analysis →

Buying

12

institutions

Selling

10

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY121.84 M15.39 B+2.83 M-7.2%0.23%
JC

Jpmorgan Chase & Co

Q2 2026

SELL20.82 M2.63 B+-13.17 M-43.3%0.15%
CA

Citadel Advisors LLC

Q2 2026

SELL5.58 M704.48 M+-487.64 K-16.6%0.08%
JH

Janus Henderson Group Plc

Q1 2026

BUY3.95 M549.84 M+2.08 M+140.6%0.13%
CP

California Public Employees Retirement System

Q2 2026

SELL2.79 M352.56 M+-794.31 K-29.4%0.20%
RT

Renaissance Technologies LLC

Q2 2026

BUY2.22 M280.14 M+64.85 K-6.6%0.39%
MM

Millennium Management LLC

Q2 2026

SELL2.18 M275.40 M+-200.24 K-17.0%0.10%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY1.48 M186.91 M+1.41 M+1818.3%0.21%
MG

Man Group Plc

Q2 2026

BUY1.24 M156.05 M+557.13 K+65.1%0.25%
AC

Aqr Capital Management LLC

Q2 2026

SELL695.43 K86.94 M+-469.37 K-46.4%0.03%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY666.68 K84.23 M+572.21 K+539.7%0.11%
VI

Voloridge Investment Management, LLC

Q2 2026

BUY559.83 K70.73 M+230.49 K+54.1%0.30%
WP

Woodline Partners LP

Q2 2026

SELL528.60 K66.78 M+-472.68 K-52.1%0.21%
BA

Bridgewater Associates, LP

Q2 2026

BUY290.88 K36.75 M+110.14 K+45.9%0.15%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUY276.38 K34.92 M+45.75 K+8.6%0.02%
AI

Ariel Investments, LLC

Q2 2026

SELL195.66 K24.72 M+-6.61 K-12.3%0.25%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY134.88 K17.04 M+30.72 K+17.4%0.03%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY123.33 K15.58 M+84.10 K+185.0%0.12%
FA

Fisher Asset Management, LLC

Q2 2026

BUY18.93 K2.39 M+7.78 K+53.9%0.00%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

SELL15.81 K2.00 M+-20.02 K-60.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL4.65 K587.23 K+-1.70 K-33.7%0.03%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-10.50 K-100.0%0.00%